Brain Tumor, Primary Clinical Trials

9 recruiting

Frequently Asked Questions

Common questions about Brain Tumor, Primary clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting

Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)

Brain TumorBrain Tumor - MetastaticBrain Tumor, Recurrent+3 more
GT Medical Technologies, Inc.600 enrolled54 locationsNCT04427384
Recruiting

Circulating Biomarkers Repository in Adults Diagnosed With Primary and Metastatic Brain Tumors

Brain Metastases, AdultBrain Tumor, Primary
Duke University300 enrolled1 locationNCT05480644
Recruiting
Phase 1

Focused Ultrasound Blood-Brain Barrier Disruption for the Treatment of High-Grade Glioma in Patients Undergoing Standard Chemotherapy

Glioblastoma Multiforme (GBM)GBMGlioma+5 more
Sunnybrook Health Sciences Centre10 enrolled1 locationNCT07179328
Recruiting

Radiation Induced Alterations in Resting State Brain Networks in Pediatric Brain Tumor Patients

Brain Tumor, Primary
Washington University School of Medicine16 enrolled1 locationNCT06185686
Recruiting

Characterization of Circulating and Tumor-infiltrating Immune Cells in Malignant Brain Tumors

Brain Tumor - MetastaticBrain Tumor, Primary
Pietro Mortini, MD, Prof.200 enrolled1 locationNCT05831631
Recruiting

Glutamate Excitotoxicity and Its Role in Glioblastoma Biology

Brain Tumor, Primary
IRCCS San Raffaele50 enrolled1 locationNCT05775458
Recruiting
Phase 1Phase 2

Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM

CancerBrain TumorBrain Cancer+6 more
Northwell Health67 enrolled1 locationNCT03213002
Recruiting
Not Applicable

FeelFit: High-intensity Interval Training to Improve Self-reported Physical Fitness in Brain Tumor Patients

ExerciseBrain Tumor, Primary
Amsterdam UMC, location VUmc36 enrolled1 locationNCT06282562
Recruiting

SeOuL cOhort of Brain Tumor MONitoring Study (SOLOMON)

MeningiomaSchwannomaBrain Tumor, Primary+2 more
Seoul National University Hospital3,000 enrolled1 locationNCT05254197